Table 2.
ELISA trend after the first MIL-AL treatment.
| Follow-Up | Dogs (n.) | Dogs with Decreased ELISA Value (n. and %) |
Dogs with Increased ELISA Value (n. and %) |
|---|---|---|---|
| 1 | 161 | 161 (100%) | 0 (0%) |
| 2 | 169 | 169 (100%) | 0 (0%) |
| 3 | 162 | 161 (99.4%) | 1 (0.6%) |
| 4 | 155 | 154 (99.4%) | 1 (0.6%) |
| 5 | 149 | 149 (100%) | 0 (0%) |
| 6 | 142 | 140 (98.6%) | 2 (1.4%) |
| 7 | 117 | 115 (98.3%) | 2 (1.7%) |
| 8 | 91 | 90 (98.9%) | 1 (1.1%) |
| 9 | 54 | 54 (100%) | 0 (0%) |
| 10 | 29 | 29 (100%) | 0 (0%) |
| 11 | 14 | 14 (100%) | 0 (0%) |
| 12 | 6 | 6 (100%) | 0 (0%) |
| 13 | 1 | 1 (100%) | 0 (0%) |
| 14 * | 1 | 1 (100%) | 0 (0%) |
* At most, 14 follow-up visits were performed after the first treatment.